Keywords: talecris, buy, see, csl, become, leader, ivig
Talecris buy could see CSL become leader in IVIG sales, says AMR
Article | 24 November 2008
Arlington Medical Resources, a USA-based market intelligence firm focused on the pharmaceutical and diagnostic imaging industries, found that over $10.0 million ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
